---
canonical_url: https://www.stockexpertai.com/earnings/kmb
last_updated: 2026-05-09T18:05:38.940Z
---

# Kimberly-Clark Corporation (KMB) Q1 FY2027 Earnings Preview

> This content was automatically generated with FMP live data + Q1 FY2026 earnings call transcript. Generated: 2026-05-09T18:05:38.508Z. Educational tool, not investment advice.

---

## Quick Summary

| Field | Value | Source |
|---|---|---|
| Price | $98.31 (▼ -1.26%) | fmp:quote |
| Market Cap | $32.6B | fmp:profile |
| 52w range | $92.42 – $144.31 | fmp:quote |
| Earnings | Fri 7 Aug | fmp:earnings-history |
| EPS estimate | $2.02 (+5% YoY) | fmp:earnings-estimate |
| Revenue estimate | $4.2B | fmp:earnings-estimate |
| Beat streak | 5/4 | fmp:earnings-history |
| Rating | B+ (overall 3/5) | fmp:ratings |
| Analyst median target | $103 (+4.8% upside) | fmp:price-target-consensus |
| MoonshotScore | 33/100 | derived |
| Council | 2/6 bullish | derived |
| Munger verdict | Fairly Valued | derived |

## Kimberly-Clark Corporation — Q1 FY2027 Expectations

Q1 consensus: revenue <strong data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvgLabel">$4.2B</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvg" title="FMP est">[FMP est]</sup>, EPS <strong data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">$2.02</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg" title="FMP est">[FMP est]</sup>. 5 consecutive quarters of beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.beatStreakCount" title="FMP earnings">[FMP earnings]</sup>.

## Quick Take

**Score:** B+ · **Stance:** HOLD · **Council:** 2/6 · **Moonshot:** 33

= MoonshotScore <strong>33</strong><sup class="cite" data-source="derived" data-field="moonshot.score" title="9-pillar formula">[9-pillar formula]</sup> + Council <strong>2/6</strong><sup class="cite" data-source="derived" data-field="council.bullishCount" title="6-lens rule">[6-lens rule]</sup>. Form 4: 0 transactions<sup class="cite" data-source="fmp:insider-trading" data-field="insider.txCount" title="FMP Form 4">[FMP Form 4]</sup>.

## Watchlist (5 metrics)

### 1. Volume Mix Growth

Kimberly-Clark is experiencing strong momentum in volume and mix growth, driven by its innovation-focused strategies.

> "Our Powering Care growth engine is enabling Kimberly-Clark to continue building industry-leading base business momentum. We are delivering differentiated science-backed innovation in all rungs of the Good, Better, Best ladder."
> — Michael Hsu, CEO, Investor Focus · Q1 FY2026

### 2. Input Cost Inflation Mitigation

Kimberly-Clark has several levers to offset rising input costs, including revenue growth management, productivity initiatives, and strategic supplier relationships.

> "As such, we have several levers in there. First one, revenue growth management. Second one, a very strong pipeline of productivity initiatives. We've delivered 2 years of 6% gross productivity back to back. And this first quarter of the year, we're already at 6%, and our plans are to deliver for the full year 6%. The pipeline is very rich."
> — Nelson Urdaneta, CFO, Investor Focus · Q1 FY2026

### 3. Innovation Driving Volume Mix

Kimberly-Clark's volume and mix growth is driven by innovation rather than promotions.

> "And the important thing, I think, as you kind of embedded in your question is that, that volume mix growth is being driven by innovation, right? And we're not renting that through promotion. The promotion is supporting the innovation. And so that's kind of the big deal for us."
> — Michael Hsu, CEO, Investor Focus · Q1 FY2026

### 4. Pricing Net Of Cost Discipline

Kimberly-Clark aims to expand margins by maintaining pricing discipline despite rising input costs.

> "And 1 concept that we've felt very important is PNOC or pricing not a commodity input cost discipline. And we expect that to be at least neutral over time, and we're going to leverage all the tools that we have to make sure that we continue to do that."
> — Michael Hsu, CEO, Investor Focus · Q1 FY2026

### 5. North America Promo Intensity

Kimberly-Clark's overall average promo intensity in North America is down versus pre-COVID levels, reflecting a focus on innovation.

> "I would say that our overall pricing was in line in the first quarter, as you saw. And in fact, our overall weighted average promo intensity in North America is down versus pre-Covid versus category levels. And that's because we're focused on driving innovation."
> — Russell Torres, Investor Focus · Q1 FY2026


## MoonshotScore Pillars

| Pillar | Score | Level | Evidence |
|---|---|---|---|
| Revenue Growth | 0.0 | weak | Q1 vs Q2: growth slowing (+0.0%, below threshold) |
| Gross Margin | 4.0 | medium | Q1: average margin (36.8%) |
| Operating Leverage | 1.0 | weak | op margin average (11.4%) |
| Cash Runway | 7.0 | strong | FCF positive but absorbed ($0.3B vs $0.4B CapEx) |
| R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) |
| Price Momentum | 4.0 | medium | RSI 50.6 balanced, 50d below |
| News Sentiment | 4.0 | medium | mixed (40% buy) |

**Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula.

## Council (7-Lens)

| Name | Stance | Context |
|---|---|---|
| Ray Dalio | bull | macro · target upside +4.8% |
| Ken Griffin | bear | flow · 50d MA below |
| Jim Simons | neutral | quant · RSI 51 |
| Klarman | neutral | value · target upside +4.8% |
| Buffett | bull | quality · ROE score 5/5 |
| Munger | neutral | valuation · target upside +4.8% |

**Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr.

## Munger Lens

- **Verdict:** Fairly Valued
- **Financial Health:** Moderate
- **Margin of Safety:** Weak
- **Interest Coverage:** Adequate
- **ROIC vs WACC:** Healthy

**Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget.

## Technical Levels

- **RSI(14):** 50.6 — dengeli — yön sinyali zayıf
- **50d MA:** $99 — hisse %0.8 altında — kısa vadeli direnç
- **200d MA:** $110 — hisse %10.9 altında — uzun vadeli baskı
- **Volume (10d):** -37%

## Past Performance (4 Quarters)

| Quarter | EPS Actual | EPS Estimate | Result | Reaction |
|---|---|---|---|---|
| Q2 FY25 | $1.92 | $1.67 | BEAT | +1.9% |
| Q3 FY25 | $1.82 | $1.75 | BEAT | -0.4% |
| Q4 FY25 | $1.86 | $1.81 | BEAT | -1.1% |
| Q1 FY26 | $1.97 | $1.93 | +2.1% EPS | -2.4% |

Q1 (April 28, 2026): EPS $1.97 vs $1.93 est<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, +2.1% beat. D+1 movement: -2.4%<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP D+1">[FMP D+1]</sup>. Decline despite beat — market reacted to guidance, not numbers.

## 3 Scenarios

### Scenario A · Beat
**Q1 EPS > $2.02 + CapEx discipline**

Threshold: EPS > $2.02<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>.

Target: Break above median target $103<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP target]</sup>; high target $110<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.high">[FMP]</sup> upper bound.

### Scenario B · In-Line
**EPS ≈ $2.02 + CapEx < $424.0M**

Threshold: EPS ≈ $2.02<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>, Q1 CapEx < $424.0M<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel">[FMP]</sup>.

Target: Consolidation in the band between current $98<sup class="cite" data-source="fmp:quote" data-field="quote.price">[FMP]</sup> and median $103<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP]</sup>.

### Scenario C · Miss
**EPS < $1.96 or CapEx ≥ $424.0M**

Threshold: EPS < $1.96<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est×0.97]</sup>.

Target: Current $98 below SMA200 $110<sup class="cite" data-source="fmp:technical" data-field="technical.sma200">[FMP]</sup>, if rejection continues, $94<sup class="cite" data-source="derived" data-field="technical.sma200" data-formula="round(sma200*0.85)">[derived]</sup> support activates.

## Risk Notes

### Primary segment below threshold
Q1: EPS $1.97 vs $1.93 beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, stock -2.4% D+1<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP">[FMP]</sup>.

### Backlog concentration
No RPO/backlog concentration disclosed in Q1 earnings call.

### Insider trading
Form 4 data is marked in the table — this page does not generate assumptions for this stock.

| Executive | Action | Amount | Date |
|---|---|---|---|


**Net:** — (0 transactions · 0 sells · 0 buys) · Q1 FY26

### CapEx shock
Q1 CapEx $424.0M<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel" title="FMP cashflow">[FMP cashflow]</sup>. Q1 op margin 11.4%<sup class="cite" data-source="fmp:income" data-field="income.quarters.0.operatingMargin" title="FMP op margin">[FMP op margin]</sup> — this level in Q1 is sensitive to CapEx revision risk.

## Wall Street Consensus

- **Median target:** $103 (+4.8% upside vs current $98)
- **High / Low:** $110 / $99
- **Buy / Hold / Sell:** 6 / 8 / 1
- **Analyst count:** 4 (last quarter), 48 all-time

## Additional Transcript Insights

### 1. volume_mix_growth

**Claim:** Kimberly-Clark is experiencing strong momentum in volume and mix growth, driven by its innovation-focused strategies.

**Evidence (transcript):** "Our Powering Care growth engine is enabling Kimberly-Clark to continue building industry-leading base business momentum. We are delivering differentiated science-backed innovation in all rungs of the Good, Better, Best ladder."

**Numbers:** 3%

### 2. innovation_driving_volume_mix

**Claim:** Kimberly-Clark's volume and mix growth is driven by innovation rather than promotions.

**Evidence (transcript):** "And the important thing, I think, as you kind of embedded in your question is that, that volume mix growth is being driven by innovation, right? And we're not renting that through promotion. The promotion is supporting the innovation. And so that's kind of the big deal for us."

**Numbers:** —

### 3. pricing_net_of_cost_discipline

**Claim:** Kimberly-Clark aims to expand margins by maintaining pricing discipline despite rising input costs.

**Evidence (transcript):** "And 1 concept that we've felt very important is PNOC or pricing not a commodity input cost discipline. And we expect that to be at least neutral over time, and we're going to leverage all the tools that we have to make sure that we continue to do that."

**Numbers:** —

### 4. input_cost_inflation_mitigation

**Claim:** Kimberly-Clark has several levers to offset rising input costs, including revenue growth management, productivity initiatives, and strategic supplier relationships.

**Evidence (transcript):** "As such, we have several levers in there. First one, revenue growth management. Second one, a very strong pipeline of productivity initiatives. We've delivered 2 years of 6% gross productivity back to back. And this first quarter of the year, we're already at 6%, and our plans are to deliver for the full year 6%. The pipeline is very rich."

**Numbers:** 6%, 6%, 6%

### 5. north_america_promo_intensity

**Claim:** Kimberly-Clark's overall average promo intensity in North America is down versus pre-COVID levels, reflecting a focus on innovation.

**Evidence (transcript):** "I would say that our overall pricing was in line in the first quarter, as you saw. And in fact, our overall weighted average promo intensity in North America is down versus pre-Covid versus category levels. And that's because we're focused on driving innovation."

**Numbers:** —


---

*Data source: FMP (live query, 2026-05-09), Q1 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*
